106 related articles for article (PubMed ID: 38762295)
1. Predicting mortality within 1 year of ART initiation in children and adolescents living with HIV in sub-Saharan Africa: a retrospective observational cohort study.
Kay A; Lukhele B; Dlamini S; Seeger A; Dlamini P; Ndabezitha S; Mthethwa N; Steffy T; Komba L; Amuge P; Ketangenyi E; Elyanu P; Munthali A; Msekandiana A; Maldonado Y; Chiao E; Kekitiinwa A; Thahane L; Mwita L; Kirchner HL; Mandalakas AM
Lancet Glob Health; 2024 Jun; 12(6):e929-e937. PubMed ID: 38762295
[TBL] [Abstract][Full Text] [Related]
2. Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study.
Iyun V; Technau KG; Vinikoor M; Yotebieng M; Vreeman R; Abuogi L; Desmonde S; Edmonds A; Amorissani-Folquet M; Davies MA;
Lancet HIV; 2021 Jun; 8(6):e353-e362. PubMed ID: 33932330
[TBL] [Abstract][Full Text] [Related]
3. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
May M; Boulle A; Phiri S; Messou E; Myer L; Wood R; Keiser O; Sterne JA; Dabis F; Egger M;
Lancet; 2010 Aug; 376(9739):449-57. PubMed ID: 20638120
[TBL] [Abstract][Full Text] [Related]
5. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.
Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO
J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853
[TBL] [Abstract][Full Text] [Related]
6. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa.
Asiimwe SB; Kanyesigye M; Bwana B; Okello S; Muyindike W
BMC Infect Dis; 2016 Feb; 16():43. PubMed ID: 26832737
[TBL] [Abstract][Full Text] [Related]
7. Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
Gupta-Wright A; Corbett EL; Wilson D; van Oosterhout JJ; Dheda K; Huerga H; Peter J; Bonnet M; Alufandika-Moyo M; Grint D; Lawn SD; Fielding K
PLoS Med; 2019 Apr; 16(4):e1002776. PubMed ID: 30951533
[TBL] [Abstract][Full Text] [Related]
8. Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa.
Bastard M; Poulet E; Nicolay N; Szumilin E; Balkan S; Pujades-Rodriguez M
Pediatr Infect Dis J; 2016 Sep; 35(9):981-6. PubMed ID: 27187757
[TBL] [Abstract][Full Text] [Related]
9. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa.
KIDS-ART-LINC Collaboration
J Acquir Immune Defic Syndr; 2008 Dec; 49(5):523-31. PubMed ID: 18989227
[TBL] [Abstract][Full Text] [Related]
12. Adolescent HIV treatment in South Africa's national HIV programme: a retrospective cohort study.
Maskew M; Bor J; MacLeod W; Carmona S; Sherman GG; Fox MP
Lancet HIV; 2019 Nov; 6(11):e760-e768. PubMed ID: 31585836
[TBL] [Abstract][Full Text] [Related]
13. Achieving Antiretroviral Therapy Uptake and Viral Suppression Among Children and Adolescents Living With HIV in the UNAIDS 90-90-90 Era Across Six Countries in Eastern and Southern Africa-Lessons From the BIPAI Network.
Bacha JM; Dlamini S; Anabwani F; Gwimile J; Kanywa JB; Farirai J; Bvumbwe M; Steffy T; Nguyen D; Wanless RS; Haq H
J Acquir Immune Defic Syndr; 2022 Jul; 90(3):300-308. PubMed ID: 35364599
[TBL] [Abstract][Full Text] [Related]
14. Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial.
Mallewa J; Szubert AJ; Mugyenyi P; Chidziva E; Thomason MJ; Chepkorir P; Abongomera G; Baleeta K; Etyang A; Warambwa C; Melly B; Mudzingwa S; Kelly C; Agutu C; Wilkes H; Nkomani S; Musiime V; Lugemwa A; Pett SL; Bwakura-Dangarembizi M; Prendergast AJ; Gibb DM; Walker AS; Berkley JA;
Lancet HIV; 2018 May; 5(5):e231-e240. PubMed ID: 29653915
[TBL] [Abstract][Full Text] [Related]
15. Equity of child and adolescent treatment, continuity of care and mortality, according to age and gender among enrollees in a large HIV programme in Tanzania.
Chaudhury S; Hertzmark E; Muya A; Sando D; Ulenga N; Machumi L; Spiegelman D; Fawzi WW
J Int AIDS Soc; 2018 Feb; 21 Suppl 1(Suppl Suppl 1):. PubMed ID: 29485735
[TBL] [Abstract][Full Text] [Related]
16. Genotype-Informed Versus Empiric Management Of VirEmia (GIVE MOVE): study protocol of an open-label randomised clinical trial in children and adolescents living with HIV in Lesotho and Tanzania.
Brown JA; Ringera I; Luoga E; Cheleboi M; Kimera N; Muhairwe J; Kayembe BP; Molapo Hlasoa M; Kabundi L; Yav CWD; Mothobi B; Thahane L; Amstutz A; Bachmann N; Mollel GJ; Bresser M; Glass TR; Paris DH; Klimkait T; Weisser M; Labhardt ND
BMC Infect Dis; 2020 Oct; 20(1):773. PubMed ID: 33076866
[TBL] [Abstract][Full Text] [Related]
17. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
18. Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.
Picat MQ; Lewis J; Musiime V; Prendergast A; Nathoo K; Kekitiinwa A; Nahirya Ntege P; Gibb DM; Thiebaut R; Walker AS; Klein N; Callard R;
PLoS Med; 2013 Oct; 10(10):e1001542. PubMed ID: 24204216
[TBL] [Abstract][Full Text] [Related]
19. The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study.
Haghighat R; Toska E; Bungane N; Cluver L
BMC Infect Dis; 2021 Jan; 21(1):60. PubMed ID: 33435861
[TBL] [Abstract][Full Text] [Related]
20. Optimal Timing of Antiretroviral Therapy Initiation in Children and Adolescents With Human Immunodeficiency Virus-Associated Pulmonary Tuberculosis.
Kay A; Mendez-Reyes J; Devezin T; Bakaya M; Steffy T; Dlamini S; Msekandiana A; Ness T; Bacha J; Amuge P; Matshaba M; Chodota M; Nyasulu P; Thahane L; Mwita L; Kekitiinwa A; DiNardo A; Lukhele B; Kirchner HL; Mandalakas A
Clin Infect Dis; 2023 Jan; 76(1):10-17. PubMed ID: 36097966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
